COVID-19 vaccine hesitancy: A telephonic survey in patients with systemic lupus erythematosusxs

Background: Vaccine against COVID-19 is an effective preventive measure; however, systemic lupus erythematosus (SLE) patients were excluded from the vaccine trials, which leads to questions regarding vaccine safety and efficacy, giving rise to vaccine hesitancy. We aim to study the prevalence of vac...

Full description

Saved in:
Bibliographic Details
Main Authors: Reuben Praharsh Kumar, Sandra Manuel, D Elizabeth, Vineeta Shobha
Format: Article
Language:English
Published: SAGE Publishing 2022-01-01
Series:Indian Journal of Rheumatology
Subjects:
Online Access:http://www.indianjrheumatol.com/article.asp?issn=0973-3698;year=2022;volume=17;issue=7;spage=406;epage=413;aulast=Kumar
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832544105350037504
author Reuben Praharsh Kumar
Sandra Manuel
D Elizabeth
Vineeta Shobha
author_facet Reuben Praharsh Kumar
Sandra Manuel
D Elizabeth
Vineeta Shobha
author_sort Reuben Praharsh Kumar
collection DOAJ
description Background: Vaccine against COVID-19 is an effective preventive measure; however, systemic lupus erythematosus (SLE) patients were excluded from the vaccine trials, which leads to questions regarding vaccine safety and efficacy, giving rise to vaccine hesitancy. We aim to study the prevalence of vaccine hesitancy among SLE patients and study the factors affecting it. Methods: The study is a cross-sectional telephone-based survey done on SLE patients. The questionnaire included a series of 15 questions pertaining to their baseline characteristics, COVID-19 infection and vaccination details, and their perceptions regarding the COVID-19 vaccine. Nonvaccinated individuals were defined as “willing” and “hesitant” based on their intent to get vaccinated. Results: Among 418 (93% women) participants, about 8% had contracted COVID-19 infection in the past. Nearly half had been vaccinated against COVID-19, and 83% had experienced one or more side effects which were largely mild. Out of the 215 nonvaccinated participants, 84% were “willing” and 16% were “hesitant.” Among the reasons for hesitancy, hasty vaccine production, fear of SLE flares, general vaccine refusal and limited transport facilities were significant. On the whole, 65.1% had a positive attitude toward the vaccine. Conclusion: Despite a low-hesitancy rate, the number of SLE patients with a negative attitude toward the COVID-19 vaccine is reasonably high, with more than half of the patients yet to be vaccinated. This highlights that the mistrust and negative perceptions of the vaccine still persists. The role of health-care providers in vaccine acceptance in SLE patients is crucial.
format Article
id doaj-art-0f9321400438400ab9f726108eae28cd
institution Kabale University
issn 0973-3698
0973-3701
language English
publishDate 2022-01-01
publisher SAGE Publishing
record_format Article
series Indian Journal of Rheumatology
spelling doaj-art-0f9321400438400ab9f726108eae28cd2025-02-03T10:55:00ZengSAGE PublishingIndian Journal of Rheumatology0973-36980973-37012022-01-0117740641310.4103/injr.injr_22_22COVID-19 vaccine hesitancy: A telephonic survey in patients with systemic lupus erythematosusxsReuben Praharsh KumarSandra ManuelD ElizabethVineeta ShobhaBackground: Vaccine against COVID-19 is an effective preventive measure; however, systemic lupus erythematosus (SLE) patients were excluded from the vaccine trials, which leads to questions regarding vaccine safety and efficacy, giving rise to vaccine hesitancy. We aim to study the prevalence of vaccine hesitancy among SLE patients and study the factors affecting it. Methods: The study is a cross-sectional telephone-based survey done on SLE patients. The questionnaire included a series of 15 questions pertaining to their baseline characteristics, COVID-19 infection and vaccination details, and their perceptions regarding the COVID-19 vaccine. Nonvaccinated individuals were defined as “willing” and “hesitant” based on their intent to get vaccinated. Results: Among 418 (93% women) participants, about 8% had contracted COVID-19 infection in the past. Nearly half had been vaccinated against COVID-19, and 83% had experienced one or more side effects which were largely mild. Out of the 215 nonvaccinated participants, 84% were “willing” and 16% were “hesitant.” Among the reasons for hesitancy, hasty vaccine production, fear of SLE flares, general vaccine refusal and limited transport facilities were significant. On the whole, 65.1% had a positive attitude toward the vaccine. Conclusion: Despite a low-hesitancy rate, the number of SLE patients with a negative attitude toward the COVID-19 vaccine is reasonably high, with more than half of the patients yet to be vaccinated. This highlights that the mistrust and negative perceptions of the vaccine still persists. The role of health-care providers in vaccine acceptance in SLE patients is crucial.http://www.indianjrheumatol.com/article.asp?issn=0973-3698;year=2022;volume=17;issue=7;spage=406;epage=413;aulast=Kumarautoimmune rheumatic diseasescovid-19covid-19 vaccinesystemic lupus erythematosusvaccine hesitancy
spellingShingle Reuben Praharsh Kumar
Sandra Manuel
D Elizabeth
Vineeta Shobha
COVID-19 vaccine hesitancy: A telephonic survey in patients with systemic lupus erythematosusxs
Indian Journal of Rheumatology
autoimmune rheumatic diseases
covid-19
covid-19 vaccine
systemic lupus erythematosus
vaccine hesitancy
title COVID-19 vaccine hesitancy: A telephonic survey in patients with systemic lupus erythematosusxs
title_full COVID-19 vaccine hesitancy: A telephonic survey in patients with systemic lupus erythematosusxs
title_fullStr COVID-19 vaccine hesitancy: A telephonic survey in patients with systemic lupus erythematosusxs
title_full_unstemmed COVID-19 vaccine hesitancy: A telephonic survey in patients with systemic lupus erythematosusxs
title_short COVID-19 vaccine hesitancy: A telephonic survey in patients with systemic lupus erythematosusxs
title_sort covid 19 vaccine hesitancy a telephonic survey in patients with systemic lupus erythematosusxs
topic autoimmune rheumatic diseases
covid-19
covid-19 vaccine
systemic lupus erythematosus
vaccine hesitancy
url http://www.indianjrheumatol.com/article.asp?issn=0973-3698;year=2022;volume=17;issue=7;spage=406;epage=413;aulast=Kumar
work_keys_str_mv AT reubenpraharshkumar covid19vaccinehesitancyatelephonicsurveyinpatientswithsystemiclupuserythematosusxs
AT sandramanuel covid19vaccinehesitancyatelephonicsurveyinpatientswithsystemiclupuserythematosusxs
AT delizabeth covid19vaccinehesitancyatelephonicsurveyinpatientswithsystemiclupuserythematosusxs
AT vineetashobha covid19vaccinehesitancyatelephonicsurveyinpatientswithsystemiclupuserythematosusxs